Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Provectus Biopharmaceuticals Inc PVCT

Provectus Biopharmaceuticals Inc is a Delaware corporation formed in 2002. The Company along with its subsidiaries is a development-stage biopharmaceutical company engaged in developing minimally invasive products for the treatment of psoriasis and other topical diseases, and certain forms of cancer including melanoma, breast cancer, and cancers of the liver. To date, the Company has no revenues from planned principal operations. It is developing its prescription drug candidates PV-10 and PH-10. It is developing PV-10 for treatment of several life threatening cancers including metastatic melanoma, liver cancer, and breast cancer. It is developing PH-10 to provide minimally invasive treatment of chronic severe skin afflictions such as psoriasis and atopic dermatitis, a type of eczema. It holds a number of U.S. patents covering the technologies it has developed and is continuing to develop for the production of prescription drugs, non-core technologies and OTC pharmaceuticals.

The Power Play by The Market Herald
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (OTCQB:PVCT)

Fundamentals Snapshot (OTCQB:PVCT)

Current News (OTCQB:PVCT)

Provectus Biopharmaceuticals Releases 2023 Stockholder Letter

GlobeNewswire January 9, 2023

Provectus Biopharmaceuticals Announces Decision to Not Undertake Reverse Split of Outstanding and Authorized Equities in 2022; Expects to Seek Same Stockholder Approval Again in 2023

GlobeNewswire December 12, 2022

Provectus Biopharmaceuticals Announces New Data from Combination Therapy Trial of Small Molecule Cancer Immunotherapy PV-10® and Keytruda® for First-Line Stage III Melanoma at Melanoma Bridge 2022

GlobeNewswire December 1, 2022

Provectus Biopharmaceuticals Announces Acceptance of Small Molecule Cancer Immunotherapy PV-10® Stage III Melanoma Abstract at Melanoma Bridge 2022

GlobeNewswire November 10, 2022

Provectus Biopharmaceuticals Announces World Health Organization Selection of "Rose Bengal Sodium" as International Nonproprietary Name for Active Pharmaceutical Ingredient

GlobeNewswire November 2, 2022

Provectus Biopharmaceuticals Expands Research Collaboration with The Rockefeller University to Investigate Clinical-Stage Immuno-Dermatology Agent PH-10 for Skin Inflammation

GlobeNewswire October 25, 2022

Provectus Biopharmaceuticals Establishes Research Collaboration with University of Texas Medical Branch at Galveston to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal for Wound Healing

GlobeNewswire September 29, 2022

Provectus Biopharmaceuticals Announces Exclusive License Option Agreement with Ophthalmic Biophysics Center of Bascom Palmer Eye Institute at University of Miami for Treatment of Eye Infections

GlobeNewswire September 21, 2022

Provectus Biopharmaceuticals Expands Sponsored Research Collaboration with University of Tennessee Health Science Center to Investigate Pharmaceutical-Grade Rose Bengal as Anti-Fungal and Anti-Oral Bacterial Agent

GlobeNewswire August 24, 2022

Opinion & Analysis (OTCQB:PVCT)

No current opinion is available.

Bullboard Posts (OTCQB:PVCT)

RE:PVCT is not dead yet

3 years but who's counting lol. Now it's 5 years from ur post and trading at the same share price. Done a little DD and on my...
Thecook100 - May 21, 2022

Where does it go from here

Looks like it may get wings!?!?!??!?!?!?
fastedster - December 29, 2017

PVCT is not dead yet

It has been 2 years since the last post and PVCT is not dead yet. In fact, though it is still in the toilet, it is looking better than it...
mplaut - June 14, 2017


Good article about PVCT  Seeking Alpha Asks Longs for Proof and Believes Shorts' Allegations Without Investigating. ...
funnyzguy - June 17, 2014

TD Ameritrade Trading Halt in PVCT

If you were a customer of TD Ameritrade and could not sell shares of PVCT on January 23, 2014, please contact us. Our law firm has been...
greenlegalteam - June 4, 2014

Schedule and Expectations in April and May for PVCT

The next 2 months have important events scheduled and other important events expected. April 6 - Poster at the American Association of...
mplaut - April 8, 2014